Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 29923982)

  • 1. Identification of recurrence-associated microRNAs in stage I lung adenocarcinoma.
    Sim J; Kim Y; Kim H; Shin SJ; Kim DH; Paik SS; Jang K
    Medicine (Baltimore); 2018 Jun; 97(25):e10996. PubMed ID: 29923982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unique microRNAs in lung adenocarcinoma groups according to major TKI sensitive EGFR mutation status.
    Pak MG; Lee CH; Lee WJ; Shin DH; Roh MS
    Diagn Pathol; 2015 Jul; 10():99. PubMed ID: 26170125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum miR-142-3p is associated with early relapse in operable lung adenocarcinoma patients.
    Kaduthanam S; Gade S; Meister M; Brase JC; Johannes M; Dienemann H; Warth A; Schnabel PA; Herth FJ; Sültmann H; Muley T; Kuner R
    Lung Cancer; 2013 May; 80(2):223-7. PubMed ID: 23410826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
    Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
    Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA profiling and prediction of recurrence/relapse-free survival in stage I lung cancer.
    Lu Y; Govindan R; Wang L; Liu PY; Goodgame B; Wen W; Sezhiyan A; Pfeifer J; Li YF; Hua X; Wang Y; Yang P; You M
    Carcinogenesis; 2012 May; 33(5):1046-54. PubMed ID: 22331473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of microRNA expression in operable non-small cell lung cancer patients.
    Skrzypski M; Czapiewski P; Goryca K; Jassem E; Wyrwicz L; Pawłowski R; Rzyman W; Biernat W; Jassem J
    Br J Cancer; 2014 Feb; 110(4):991-1000. PubMed ID: 24448358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non-Small Cell Lung Cancer Using Next-Generation Sequencing.
    Jin X; Chen Y; Chen H; Fei S; Chen D; Cai X; Liu L; Lin B; Su H; Zhao L; Su M; Pan H; Shen L; Xie D; Xie C
    Clin Cancer Res; 2017 Sep; 23(17):5311-5319. PubMed ID: 28606918
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics.
    Li CY; Zhang WW; Xiang JL; Wang XH; Li J; Wang JL
    Chin Med J (Engl); 2019 Sep; 132(18):2213-2222. PubMed ID: 31490264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-139-5p as a novel serum biomarker for recurrence and metastasis in colorectal cancer.
    Miyoshi J; Toden S; Yoshida K; Toiyama Y; Alberts SR; Kusunoki M; Sinicrope FA; Goel A
    Sci Rep; 2017 Mar; 7():43393. PubMed ID: 28262692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and functional characterization of microRNAs reveal a potential role in gastric cancer progression.
    Li CY; Liang GY; Yao WZ; Sui J; Shen X; Zhang YQ; Peng H; Hong WW; Ye YC; Zhang ZY; Zhang WH; Yin LH; Pu YP
    Clin Transl Oncol; 2017 Feb; 19(2):162-172. PubMed ID: 27173517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of microRNA expression levels to predict outcomes in resected stage I non-small cell lung cancer.
    Duncavage E; Goodgame B; Sezhiyan A; Govindan R; Pfeifer J
    J Thorac Oncol; 2010 Nov; 5(11):1755-63. PubMed ID: 20975375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive analysis of aberrantly expressed microRNA profiles reveals potential biomarkers of human lung adenocarcinoma progression.
    Sui J; Yang RS; Xu SY; Zhang YQ; Li CY; Yang S; Yin LH; Pu YP; Liang GY
    Oncol Rep; 2017 Oct; 38(4):2453-2463. PubMed ID: 28791371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer.
    Krishnan P; Ghosh S; Wang B; Li D; Narasimhan A; Berendt R; Graham K; Mackey JR; Kovalchuk O; Damaraju S
    BMC Genomics; 2015 Sep; 16():735. PubMed ID: 26416693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
    Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
    J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of miR-181c as a predictive marker of recurrence in stage II colorectal cancer.
    Yamazaki N; Koga Y; Taniguchi H; Kojima M; Kanemitsu Y; Saito N; Matsumura Y
    Oncotarget; 2017 Jan; 8(4):6970-6983. PubMed ID: 28036302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-126-3p and miR-451a correlate with clinicopathological features of lung adenocarcinoma: The underlying molecular mechanisms.
    Chen Q; Hu H; Jiao D; Yan J; Xu W; Tang X; Chen J; Wang J
    Oncol Rep; 2016 Aug; 36(2):909-17. PubMed ID: 27277197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A MicroRNA cluster at 14q32 drives aggressive lung adenocarcinoma.
    Nadal E; Zhong J; Lin J; Reddy RM; Ramnath N; Orringer MB; Chang AC; Beer DG; Chen G
    Clin Cancer Res; 2014 Jun; 20(12):3107-17. PubMed ID: 24833665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative microRNA and gene profiling data analysis reveals novel biomarkers and mechanisms for lung cancer.
    Hu L; Ai J; Long H; Liu W; Wang X; Zuo Y; Li Y; Wu Q; Deng Y
    Oncotarget; 2016 Feb; 7(8):8441-54. PubMed ID: 26870998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR 21-5p as a predictor of recurrence in young gastric cancer patients.
    Park SK; Park YS; Ahn JY; Do EJ; Kim D; Kim JE; Jung K; Byeon JS; Ye BD; Yang DH; Park SH; Hwang SW; Jung HY; Myung SJ
    J Gastroenterol Hepatol; 2016 Aug; 31(8):1429-35. PubMed ID: 26824898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
    Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
    Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.